Advertisement

Topics

Bayer Pharmaceuticals Company Profile

21:59 EDT 19th June 2018 | BioPortfolio

We offer our customers a wide variety of products and services in areas ranging from health care and CropScience to plastics and specialty chemicals. Bayer is research-based and is aiming for technological leadership in its core activities.

Our goals are to steadily increase corporate value and generate a high value added for the benefit of our stockholders, our employees and the community in every country in which we operate. We believe that our technical and commercial expertise involves responsibility to work for the common good and contribute to sustainable

development.

Location

400 Morgan Lane
West Haven
CT
06516
United States of America

Contact

Phone: 203 812 2970
Fax: 203 812 2686


News Articles [1314 Associated News Articles listed on BioPortfolio]

Change the byword at Bayer to keep pharma growth going

Continued growth in Bayer’s Pharmaceuticals unit ensured that the German life sciences group’s 2017…

Bayer bei Monsanto auf Zielgerade - Kapitalerhöhung

Die teuerste Übernahme eines deutschen Unternehmens im Ausland: Bayer schluckt Monsanto. Die Aktionäre müssen mithelfen. Bayer braucht Kapital. Wie sind da die Aussichten für die Bayer-Aktie, Vivi...

wikifolio whispers p.m. zu Evotec, WireCard, Bayer ...

Bayer -2.35% Tiedemann (TIEDE001): Kauf einer Aktie zu 100,059 € --- Bilanz -48,634 € (28.05. 15:10) >> mehr comments zu Bayer: www.boerse-social.com/launch/aktie/bayer_ag Bayer -2.35% Tiedemann (...

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19022018] Prices from USD $350

Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Bayer Healthcare Pharmaceuticals Mergers Acquisitions MA, Partnerships Al...

UPDATE/China genehmigt Bayer Monsanto-Übernahme unter Auflagen

--Bayer muss sich von Saatgütern trennen --China fordert Zugang zu Digital-Farming-Plattformen --Bayer sieht Auflagen mit BASF-Verkaufsplänen als erfüllt (NEU: Stellungnahme von Bayer) Von Olaf Ri....

Bayer shareholder Temasek to boost share capital

Bayer AG said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company. Temasek has subscribed to 31 million new Bayer shares, which equa...

The Fight Against Bayer's Essure Continues As The FDA Orders New Safety Measures

NewsEven after more than 5,000 women have complained about Essure, a contraceptive device, Bayer Pharmaceuticals continues to make and sell this lucrative device.

Bayer stock: Interesting dividend?

During the last week, Robert Sasse took a closer look at Bayer. This is his conclusion: Ever since 2006 the Bayer shareholders received rising dividends. There was only one exception. Only in 2009 ...

PubMed Articles [143 Associated PubMed Articles listed on BioPortfolio]

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

Progestin therapy has been accepted as therapy for low- and medium-risk endometrial hyperplasia. The aim of this study was to investigate the efficacy of the low-dose levonorgestrel-impregnated intrau...

Interrupted Bayer-Villiger Rearrangement: Building A Stereoelectronic Trap for the Criegee Intermediate.

The instability of hydroxyl peroxyesters, the elusive Criegee intermediates of the Bayer-Villiger rearrangement, can be alleviated by selective deactivation of stereoelectronic effects that promote th...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [244 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-Fasting Conditions

The purpose of this study is compare the relative bioavailability of Nifedipine ER tablets 60 mg by Abrica Pharmaceuticals LLLP with that of ADALAT® CC Extended Release Tablets 60 mg by ...

International PMS Study - KOGENATE Bayer

To evaluate long-term safety (primarily by recording adverse events including inhibitors), efficacy and patient acceptance of KOGENATE Bayer in home treatment either on prophylaxis or on d...

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

The aim of this international prospective, non-interventional post-marketing surveillance study is to obtain data on treatment procedures, long-term safety and efficacy and patient accepta...

Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-t

This study aims is to evaluate, two hours after a single administration, the rate of sustained response produced by the association Geolab consisting of acetylsalicylic acid, sodium bicarb...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Companies [1371 Associated Companies listed on BioPortfolio]

Bayer Animal Health

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combine...

Bayer USA Foundation

The Bayer USA Foundation is an endowed 501(c)(3) entity and is the primary source of Bayer Corporation’s philanthropy in the United States. With a programmatic focus on the e...

Bayer MaterialScience AG

Bayer MaterialScience AG is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also s...

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes care, supporting customers in 100 countries and, for more than 40 years, has led the way in diabetes care product innovation. Today, Bayer Diabete...

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

More Information about "Bayer Pharmaceuticals" on BioPortfolio

We have published hundreds of Bayer Pharmaceuticals news stories on BioPortfolio along with dozens of Bayer Pharmaceuticals Clinical Trials and PubMed Articles about Bayer Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bayer Pharmaceuticals Companies in our database. You can also find out about relevant Bayer Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record